Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

Name: Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma
License: Public Domain

University of Washington

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diffuse large b-cell lymphoma, grade 3b follicular lymphoma, high grade b-cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 467578
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.